Lisa Flanigan
About Lisa Flanigan
Lisa Flanigan is a Senior Clinical Trial Manager at Syneos Health, currently seconded to Bristol Myers Squibb Australia, with over 10 years of experience in clinical research.
Company
Lisa Flanigan is currently associated with Syneos Health and is seconded to Bristol Myers Squibb (BMS) Australia. At BMS, she holds the position of Senior Clinical Trial Manager, where she applies her extensive experience and expertise in overseeing clinical trials.
Previous Experience
Lisa Flanigan has an extensive background in clinical research, with significant roles at various notable companies. Prior to her current position, she worked at Clinical Network Services (CNS) Pty Ltd as a Senior Clinical Research Associate (SCRA) from 2018 to 2020. She also briefly worked at Syneos Health as a Senior Clinical Research Associate II in 2018. Her earlier roles include a six-year tenure at INC Research from 2011 to 2017, where she progressed from Senior Clinical Research Associate I to Senior Clinical Research Associate II. Prior to INC, she worked as a CRA II at Quintiles and as a CRA at PPD.
Education and Training
Lisa Flanigan studied and trained at Alfred Hospital from 1987 to 1990. This foundational education prepared her for a successful career in clinical research, particularly in roles that demand high levels of scientific and technical knowledge.
Specialization and Expertise
Lisa specializes in Phase 1 clinical studies and has built expertise across various therapeutic areas. Her clinical research expertise extends to Oncology/Hematology, Cardiovascular, Neurology, pre-eclampsia, and Gastroenterology. Her multifaceted experience makes her a valuable asset in the field of clinical trials and research.
Background in Clinical Research
With over 10 years of clinical research experience, Lisa Flanigan brings extensive knowledge and technical skills to her roles. She began her career as a Research/Trials Coordinator at Alfred Hospital, where she worked for nine years from 1996 to 2005. This long-standing commitment to clinical research underscores her expertise and dedication to the field.